Informazioni e Risorse sul Diabete
Advancing emerging research may transform dietary management of type 2 diabetes October 28, 2021 — Pendulum Therapeutics, a trailblazer in microbiome science and a pioneer in DNA sequencing, is leading…
Pioneering Microbiome Company Demonstrates Significant Clinical Results from Use of Microbiome-Based Synbiotic in Patients with Type 2 Diabetes SAN FRANCISCO, July 20, 2020 Pendulum Therapeutics, an evidence-based microbiome company, announced today…
Pendulum® Glucose Control Targets the Gut Microbiome to Manage Blood Sugar Levels. SAN FRANCISCO, June 4, 2020 Pendulum Therapeutics, a cutting-edge microbiome company dedicated to making people healthier through microbiome-targeted solutions, announced…